Journal of Biological Engineering最新文献

筛选
英文 中文
Dual pH/temperature-responsive β-cyclodextrin-grafted cellulose nanocrystals for co-delivery of methotrexate and curcumin to MCF-7 cells. 双pH/温度响应β-环糊精接枝纤维素纳米晶体用于MCF-7细胞中甲氨蝶呤和姜黄素的共递送。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-08-05 DOI: 10.1186/s13036-026-00738-6
Sevil Vaghefi Moghaddam, Fatemeh Abedi, Soodabeh Davaran, Hamidreza Pazoki-Toroudi, Shirin Ahmadi, Sepideh Zununi Vahed, Shahram Dabiri Oskui, Mozhgan Effat Panahi
{"title":"Dual pH/temperature-responsive β-cyclodextrin-grafted cellulose nanocrystals for co-delivery of methotrexate and curcumin to MCF-7 cells.","authors":"Sevil Vaghefi Moghaddam, Fatemeh Abedi, Soodabeh Davaran, Hamidreza Pazoki-Toroudi, Shirin Ahmadi, Sepideh Zununi Vahed, Shahram Dabiri Oskui, Mozhgan Effat Panahi","doi":"10.1186/s13036-026-00738-6","DOIUrl":"10.1186/s13036-026-00738-6","url":null,"abstract":"<p><p>The development of smart natural delivery systems that can deliver several chemotherapeutics in a controlled manner is a promising idea to enhance cancer treatment efficacy. In this study, we designed and synthesized a smart, dual pH- and thermo-responsive nanocarrier system based on β-CD-g-BCN, which was further functionalized with MSP and copolymerized with NIPAAm and DMAEMA to yield the final β-CD-g-BCN@MSP@PND formulation. The nanocarriers indicated efficient encapsulation of two anticancer agents, MTX and CUR, with encapsulation efficiencies of 64.5% and 87%, respectively. Successful functionalization and thermal stability were validated by characterization using FTIR, FESEM, TEM, DLS, zeta potential, and TGA. The nanoparticles exhibited sharp LCST behavior (~ 40.5 °C), which facilitates temperature-sensitive drug release. Improved drug release under acidic (pH 5.8) and hyperthermic (40 °C) conditions, simulating the tumor, was confirmed by in vitro release studies. Based on cytotoxicity studies, the MTX/CUR-loaded system had strong synergistic effects (CI < 0.1) on MCF-7 cells, while blank nanoparticles showed negligible toxicity. The time-dependent cellular uptake of RhB-labeled nanocarriers was validated by fluorescence microscopy. Overall, the prepared dual-responsive nanocarrier shows great promise for effective breast cancer treatment. However, this study is limited to in vitro evaluations, and further in vivo studies are required to confirm the therapeutic potential of the developed nanocarrier.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13726300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light assisted activation of platelet-rich plasma for enhanced and controlled release of growth factors: a technology-driven proof-of-concept framework. 光辅助激活富血小板血浆以增强和控制生长因子的释放:技术驱动的概念验证框架。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-08-04 DOI: 10.1186/s13036-026-00733-x
Sarassunta Ucci, Valeria Iazzetta, Sara Spaziani, Antonio Iele, Giancarlo Luongo, Saverio Graziano, Eugenio Caradonna, Armando Ricciardi, Marco Pisco, Anna Aliberti, Andrea Cusano
{"title":"Light assisted activation of platelet-rich plasma for enhanced and controlled release of growth factors: a technology-driven proof-of-concept framework.","authors":"Sarassunta Ucci, Valeria Iazzetta, Sara Spaziani, Antonio Iele, Giancarlo Luongo, Saverio Graziano, Eugenio Caradonna, Armando Ricciardi, Marco Pisco, Anna Aliberti, Andrea Cusano","doi":"10.1186/s13036-026-00733-x","DOIUrl":"10.1186/s13036-026-00733-x","url":null,"abstract":"<p><strong>Background: </strong>Platelet-rich plasma (PRP) is widely used in regenerative medicine due to its high content of growth factors and bioactive molecules involved in tissue repair and regeneration. However, the lack of standardized preparation protocols leads to significant variability in clinical outcomes. To address this limitation, photobiomodulation (PBM) has emerged as a promising alternative to conventional chemical activation methods, enabling more controlled PRP stimulation and sustained growth factor release, while avoiding the rapid burst secretion and potential platelet damage induced by thrombin or CaCl₂. In this study, we developed a compact illumination system capable of delivering fluence-controlled irradiation at 660 and 830 nm for ex vivo PRP activation and evaluated its effects using an integrated analytical approach combining ELISA and Raman spectroscopy.</p><p><strong>Results: </strong>The effects of different fluences (10-15 J/cm<sup>2</sup>) and incubation times (1, 24, 48 and 72 h) were systematically investigated to evaluate dose-response effects on PRP activation. To support real-time, label-free monitoring and facilitate clinical translation, Raman spectroscopy was assessed as a non-destructive analytical tool, with ELISA used for reference validation. Our results show that PBM induces reproducible biochemical changes in PRP, with Raman spectral signatures at 72 h (10 and 15 J/cm²) correlating with ELISA growth factor release.</p><p><strong>Conclusions: </strong>This study demonstrates that controlled light-based stimulation enables tunable PRP activation while preserving platelet structural integrity. Integrating a compact PBM device with portable Raman spectroscopy provides a non-destructive, clinically compatible strategy for both modulating and monitoring PRP activation. This approach establishes a technological framework for standardized, dose-defined PRP photoactivation and supports the development of translational, light-guided regenerative therapies.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13726223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autologous hinge-masked anti-TNFα antibody to mitigate immunogenicity, antigen sink effects, and anti-idiotypic antibody interference. 自体铰链屏蔽抗tnf α抗体,减轻免疫原性、抗原汇效应和抗独特型抗体干扰。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-08-01 DOI: 10.1186/s13036-026-00741-x
Bo-Cheng Huang, Yun-Chi Lu, Chih-Hung Chuang, Shih-Ting Hong, Kai-Wen Ho, Yi-An Cheng, Tzu-Yi Liao, En-Shuo Liu, Jun-Min Liao, Chiao-Yun Chen, Tian-Lu Cheng, I-Ju Chen, Wen-Wei Lin
{"title":"Autologous hinge-masked anti-TNFα antibody to mitigate immunogenicity, antigen sink effects, and anti-idiotypic antibody interference.","authors":"Bo-Cheng Huang, Yun-Chi Lu, Chih-Hung Chuang, Shih-Ting Hong, Kai-Wen Ho, Yi-An Cheng, Tzu-Yi Liao, En-Shuo Liu, Jun-Min Liao, Chiao-Yun Chen, Tian-Lu Cheng, I-Ju Chen, Wen-Wei Lin","doi":"10.1186/s13036-026-00741-x","DOIUrl":"10.1186/s13036-026-00741-x","url":null,"abstract":"<p><strong>Background: </strong>Monoclonal antibody (mAb) therapies are limited by factors affecting their pharmacokinetics (PK), such as anti-idiotypic antibodies (anti-ID Abs) and the antigen sink effect. To address this, we developed six pro-anti-TNFα Abs (pro-Infliximab) incorporating unique hinge regions (\"Ab locks\") from different immunoglobulin subtypes linked via protease-sensitive peptides. The steric shielding formed by the endogenous hinge's disulfide bonds provides a modular design that can be applied to various Ab drugs with minimal structural modification. Compared to other spatial hindrance strategies, this Ab lock approach is anticipated to offer a favorable immunogenicity profile.</p><p><strong>Results: </strong>Among the variants, The IgG1 hinge exhibited the most robust masking capability among the evaluated domains, resulting in a 128-fold reduction in Infliximab's antigen binding. IgG1 pro-Infliximab demonstrated low immunogenicity after repeated dosing and maintained stable PK in both naïve and immunized mice, retaining 74.2% serum levels one hour after TNFα challenge. It also reduced anti-ID Ab binding by 87.3-fold, while showing a trend toward decreasing Ab-mediated drug clearance in these treated mice.</p><p><strong>Conclusions: </strong>This IgG1 Ab lock strategy provides binding-level proof of concept for several pro-Abs, offering the potential to mitigate immunogenicity. It blocked systemic hTNFα in an acute target challenge model and reduced clearance to preserve pro-Infliximab PK, ultimately helping to enhance patient quality of life.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotic-hydrogel systems for microbiome-associated diseases: design principles, preclinical evidence, and translational challenges. 微生物组相关疾病的益生菌-水凝胶系统:设计原则、临床前证据和转化挑战。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-08-01 DOI: 10.1186/s13036-026-00740-y
Yu Zhou, Guannan Zhang, Qinying Shi, Jialing Liu, Ying Lu, Jianbo Song
{"title":"Probiotic-hydrogel systems for microbiome-associated diseases: design principles, preclinical evidence, and translational challenges.","authors":"Yu Zhou, Guannan Zhang, Qinying Shi, Jialing Liu, Ying Lu, Jianbo Song","doi":"10.1186/s13036-026-00740-y","DOIUrl":"https://doi.org/10.1186/s13036-026-00740-y","url":null,"abstract":"<p><p>The human microbiome provides a robust ecosystem for mucosal barrier function, immune regulation, metabolism, and resistance to pathogen infection. Dysbiosis causes inflammatory bowel disease, oral inflammation, wound damage, skin disease, and cancer-related immune dysregulation. Current probiotic therapy is limited by low survival during storage and administration, low oral bioavailability, short retention time, and insufficient targeting. Probiotic-hydrogel systems combine viable microorganisms with natural or synthetic polymer networks to promote probiotic protection, local retention, and controlled release. They can also incorporate prebiotics, engineered bacteria, oxygen-releasing agents, antioxidants, growth factors, drugs, or advanced manufacturing techniques such as microfluidics and 3D printing. Recent preclinical studies suggest that probiotic-hydrogel can modulate local microbes, suppress pathogens, control inflammation, support barrier repair, and promote tissue regeneration. However, most evidence is far from clinical, and human data are limited to a small number of oral and periodontal applications. In this review, we summarize the design strategies, encapsulation approaches, mechanistic frameworks, disease-based evidence, and translational challenges of probiotic-hydrogel. In particular, we paid attention to evidence level, safety, manufacturing, regulatory classification, product stability, clinical trial design. Such issues need to be well understood before probiotic-hydrogel can move from experimental platforms to clinically applicable microbiome treatments.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
aspA promoter as a tumor microenvironment-responsive autoswitch for anticancer agent expression in Escherichia coli. aspA启动子在大肠杆菌中作为肿瘤微环境响应性的抗癌药物表达自开关。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-31 DOI: 10.1186/s13036-026-00743-9
Dogeun Lee, Seyeon Hong, Jihyeon Kim, Miryoung Song, Daejin Lim
{"title":"aspA promoter as a tumor microenvironment-responsive autoswitch for anticancer agent expression in Escherichia coli.","authors":"Dogeun Lee, Seyeon Hong, Jihyeon Kim, Miryoung Song, Daejin Lim","doi":"10.1186/s13036-026-00743-9","DOIUrl":"10.1186/s13036-026-00743-9","url":null,"abstract":"<p><p>Bacterial cancer therapy has emerged as a promising strategy for the local delivery of anticancer agents to solid tumors because bacteria preferentially colonize the tumor microenvironment (TME). However, strategies for exploiting metabolic features of the TME to achieve tumor-selective expression of anticancer agents remain limited. Here, we present a tumor-responsive gene expression system in Escherichia coli for tumor-selective expression of the recombinant immunotoxin psp-TGFa-PE38 (TP), exploiting its intrinsic ability to sense metabolic cues in the TME. To identify such TME-associated metabolic cues, we examined tumor metabolites in CT26 tumor-bearing mice and confirmed that tumors contained > 3-fold lower glucose and > 5-fold higher fumarate levels than those in the liver. In response to this nutrient heterogeneity, E. coli upregulated genes involved in fumarate respiration, including frdA, dctA, dcuB, and aspA, in the DcuSR regulon. aspA was most upregulated (65-fold) in tumors, which is indicative of the strongest activity of its promoter in the TME. We used the aspA promoter (P<sub>aspA</sub>) as a tumor-specific switch to control TP expression, targeting secreted functional TP and inducing cytotoxicity in vitro. TP was specifically expressed by P<sub>aspA</sub> in tumors, reducing the tumor size by 2.8-fold and extending survival by 35 days in vivo. Overall, these results suggest that the potential of P<sub>aspA</sub> as a tumor-specific expression system.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13715239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149286971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stealth-body Fc engineering platform enables complete effector silencing in antibody and ADC therapeutics. 隐形体Fc工程平台可以在抗体和ADC治疗中实现完全的效应沉默。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-29 DOI: 10.1186/s13036-026-00735-9
Suyeon Kim, Migyeong Jo, Munsu Kyung, Woo Hyung Ko, Wonju Lee, Kihwan Chang, Pedro Lee, Sungkuk Cho, Seongin Seomun, Byoung Joon Ko, Tae-Erk Kim, Jungmin Choi, Sang Taek Jung
{"title":"A stealth-body Fc engineering platform enables complete effector silencing in antibody and ADC therapeutics.","authors":"Suyeon Kim, Migyeong Jo, Munsu Kyung, Woo Hyung Ko, Wonju Lee, Kihwan Chang, Pedro Lee, Sungkuk Cho, Seongin Seomun, Byoung Joon Ko, Tae-Erk Kim, Jungmin Choi, Sang Taek Jung","doi":"10.1186/s13036-026-00735-9","DOIUrl":"10.1186/s13036-026-00735-9","url":null,"abstract":"<p><strong>Background: </strong>The development of next-generation antibody therapeutics requires Fc scaffolds that suppress unwanted effector functions while preserving core developability attributes. Existing effector-attenuated Fc backbones, however, retain residual interactions with Fcγ receptors (FcγRs) and C1q, highlighting a persistent design limitation in achieving complete effector silencing without compromising glycosylation, FcRn-mediated persistence, and manufacturability. This is particularly relevant for formats in which Fc effector function is undesirable, including immune-engaging antibodies, CD47 blockers, and antibody-drug conjugates (ADCs). Accordingly, a robust Fc engineering framework enabling complete and transferable effector silencing across antibody modalities is required.</p><p><strong>Results: </strong>We developed Stealth-Body (SB) Fc variants, a fully effector-silenced Fc platform that abolishes Fc-mediated immune engagement while maintaining native-like glycosylation, pharmacokinetics, and manufacturability. Using a CHO cell display system with directed evolution guided by cross-species sequence features from goat IgG, we identified human glycosylated IgG1 variants (SB1, SB5, SB6) that abrogated binding to all human FcγRs and C1q, and to all murine and cynomolgus FcγRs. SB Fc retained pH-dependent FcRn binding, antigen recognition, thermostability, and expression, with in vivo persistence comparable to wild-type IgG1. Incorporation of SB Fc into trastuzumab, rituximab, and ADCs abolished ADCC, ADCP, and CDC, while integration into a CD47-targeting IgG-CD40L fusion protein mitigated hematologic toxicity without impairing immune activation.</p><p><strong>Conclusions: </strong>Collectively, SB Fc variants represent a generalizable, effector-null Fc scaffold that enables complete and transferable silencing of Fc-mediated immune functions while preserving key developability attributes. This platform expands the therapeutic window of antibody therapeutics through precise control of Fc activity across diverse modalities.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149267626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An optimized CRISPR/Cas9-based genome editing platform enhances bacteriocin production in Lactiplantibacillus plantarum. 优化的基于CRISPR/ cas9的基因组编辑平台增强了植物乳杆菌细菌素的产生
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-29 DOI: 10.1186/s13036-026-00739-5
Rajat Anand, Rudolf Lütticken, Laura De Laporte, Andreas Herrmann, Elisabeth Heine
{"title":"An optimized CRISPR/Cas9-based genome editing platform enhances bacteriocin production in Lactiplantibacillus plantarum.","authors":"Rajat Anand, Rudolf Lütticken, Laura De Laporte, Andreas Herrmann, Elisabeth Heine","doi":"10.1186/s13036-026-00739-5","DOIUrl":"10.1186/s13036-026-00739-5","url":null,"abstract":"<p><p>Efficient genetic engineering of lactic acid bacteria remains technically challenging due to their thick peptidoglycan cell wall, low transformation efficiency, strain-specific restriction-modification systems, and sensitivity to Cas9-induced double-strand breaks. In this study, we adapted an established CRISPR/Cas9 approach for the targeted disruption of plnD, a key negative regulatory gene within the plantaricin quorum-sensing network of Lactiplantibacillus plantarum 8P-A3 through extensive optimization of transformation and genome-editing conditions. The genetically modified strain exhibited upregulation of plnA, plnE, and plnF, accompanied by elevated antimicrobial activity. These findings underscore the feasibility of rationally reconfiguring a quorum-sensing-associated regulatory circuit and provide a practical strategy for successful genetic engineering in L. plantarum for elevated bacteriocin production.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13420864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148619799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering compact bacterial combinatorial promoters for two-input chemical AND switching. 工程紧凑型细菌组合启动子双输入化学与开关。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-27 DOI: 10.1186/s13036-026-00728-8
Satya Prakash, Alfonso Jaramillo
{"title":"Engineering compact bacterial combinatorial promoters for two-input chemical AND switching.","authors":"Satya Prakash, Alfonso Jaramillo","doi":"10.1186/s13036-026-00728-8","DOIUrl":"10.1186/s13036-026-00728-8","url":null,"abstract":"<p><p>Engineering compact bacterial promoters that integrate two chemical inputs would simplify biosensors, synthetic circuits, and dynamic metabolic control, but such promoters remain difficult to build because a second operator can increase partial-state leak, reduce the fully induced state, and create sequence- or reporter-context effects. Here we engineered 12 compact Marionette-derived two-input promoter architectures in Escherichia coli by combining defined template scaffolds with added operators, then quantified 19 reporter-specific four-state truth tables under a predefined operational criterion for chemical-input AND behaviour. Single-input template-promoter controls in matched reporter contexts helped separate weak parent-scaffold output from effects introduced by the second operator. Nine curated architectures passed in at least one reporter, and selected constructs delivered high-utility AND responses, including [11]/max-off separation up to > 1,367. The full pass-fail dataset showed that a statistically higher [11] state does not necessarily create a useful switch. Practical utility depended mainly on suppressing [10] and [01] leakage, matching the template scaffold to the inserted operator, and controlling long-operator orientation and local sequence context. Reciprocal architectures behaved differently, and 4 of 7 dual-reporter architectures changed operational classification with reporter context. Thus, this work delivers a compact set of candidate Marionette-compatible two-input promoter parts and a source-traceable design framework for engineering bacterial chemical-input AND switches.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harmine-loaded PCL/PVA multilayer nanofibers for targeted pancreatic cancer therapy. 载毒碱PCL/PVA多层纳米纤维用于胰腺癌靶向治疗。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-23 DOI: 10.1186/s13036-026-00737-7
Zeynab Zamanzadeh, Behzad Khansarinejad, Mahdieh Mondanizadeh, Shima Masodii, Hadi Karami
{"title":"Harmine-loaded PCL/PVA multilayer nanofibers for targeted pancreatic cancer therapy.","authors":"Zeynab Zamanzadeh, Behzad Khansarinejad, Mahdieh Mondanizadeh, Shima Masodii, Hadi Karami","doi":"10.1186/s13036-026-00737-7","DOIUrl":"10.1186/s13036-026-00737-7","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer remains one of the deadliest malignancies because of late diagnosis, rapid metastasis, and poor response to conventional therapies. Localized drug delivery systems based on electrospun nanofibers may improve therapeutic outcomes by enabling sustained local drug release while minimizing systemic toxicity. This study developed harmine (HAR)-loaded multilayer nanofibers using polycaprolactone (PCL) and polyvinyl alcohol (PVA) and evaluated their physicochemical characteristics and anti-cancer effects against ASPC-1 pancreatic cancer cells.</p><p><strong>Results: </strong>Bilayer and trilayer HAR-loaded nanofibers were successfully fabricated with uniform, bead-free morphology. Morphology was characterized by FE-SEM, and drug incorporation was confirmed by FTIR analysis. The multilayer architecture demonstrated favorable swelling behavior, controlled degradation, and regulated water vapor transmission. Drug release studies showed an initial burst release (~ 16% within 6 h), followed by sustained HAR release reaching approximately 68% over 72 h. Blank nanofibers exhibited high biocompatibility (> 97% cell viability). Compared with free HAR, HAR-loaded nanofibers (NFs) significantly enhanced anti-cancer efficacy and achieved nearly complete suppression of viability in ASPC-1 cells after 72 h. Functional analyses demonstrated substantial inhibition of cell migration and colony formation. Molecular evaluation revealed significant apoptosis induction through upregulation of BAX and CASP3 and downregulation of BCL-2, with the PCL/PVAHAR formulation showing the strongest response (BAX ≈ 4.8-fold, CASP3 ≈ 3.9-fold, BCL-2 ≈ 0.35-fold; BAX/BCL-2 ratio ≈ 13.7). STRING analysis further supported the involvement of apoptosis-associated signaling pathways.</p><p><strong>Conclusions: </strong>HAR-loaded PCL/PVA nanofibers provide an effective localized drug-delivery platform with sustained release and enhanced anti-pancreatic-cancer activity compared with free HAR. These findings support the further development of this system as a potential implantable therapeutic strategy for post-resection pancreatic cancer management.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13679269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NIR-responsive cetuximab-functionalized chitosan-polydopamine hydrogel Co- delivering Ca2+ and gefitinib for EGFR-targeted esophageal cancer therapy via Ca2+- mediated cytotoxicity and potential immunomodulatory effects. 通过Ca2+介导的细胞毒性和潜在的免疫调节作用,西妥昔单抗功能化壳聚糖聚多巴胺水凝胶Co-递送Ca2+和吉非替尼用于egfr靶向食管癌治疗。
IF 6.3 3区 生物学
Journal of Biological Engineering Pub Date : 2026-07-22 DOI: 10.1186/s13036-026-00726-w
Jing Chen, Shirong Wu, Yu Zhang, Ya Zhao, Mengqi Xiang, Liqiong Hao
{"title":"NIR-responsive cetuximab-functionalized chitosan-polydopamine hydrogel Co- delivering Ca<sup>2+</sup> and gefitinib for EGFR-targeted esophageal cancer therapy via Ca<sup>2+</sup>- mediated cytotoxicity and potential immunomodulatory effects.","authors":"Jing Chen, Shirong Wu, Yu Zhang, Ya Zhao, Mengqi Xiang, Liqiong Hao","doi":"10.1186/s13036-026-00726-w","DOIUrl":"10.1186/s13036-026-00726-w","url":null,"abstract":"<p><p>The current study presents the development of a Cetuximab (CTX)-functionalized chitosan-polydopamine (CS-PDA) hydrogel co-delivering calcium ions (Ca<sup>2 +</sup>) and Gefitinib (GFT) for EGFR-targeted therapy against esophageal cancer through the induction of Ca<sup>2+</sup> mediated cell death and potential immune modulatory effects. FTIR analysis confirmed the functional groups present in the fabricated hydrogel, while UV-Vis spectroscopy verified successful drug incorporation, and SEM analysis revealed a porous morphology suitable for efficient drug encapsulation. The hydrogel shows high drug loading efficiencies of 78.5 ± 2.3% for Ca<sup>2 +</sup> and 81.6 ± 3.1% for GFT, with pH-responsive drug release reaching up to 70% under acidic conditions. NIR-activated CTX-CS-pDA@Ca<sup>2 +</sup>/GFT hydrogel showed superior cytotoxicity in KYSE-140 cells, with significantly lower IC₅₀ values than free GFT. Further, JC-1 and AO/EB staining confirmed mitochondrial depolarization and apoptosis induction, while flow cytometry demonstrated that CTX-CS-pDA@Ca<sup>2 +</sup>/GFT + NIR markedly induced apoptosis in KYSE-140 cells by combining EGFR inhibition, Ca<sup>2 +</sup> -mediated stress, and NIR-enhanced ROS generation, resulting in reduced cell viability and increased apoptotic populations. Calcium imaging further validated intracellular Ca<sup>2 +</sup> accumulation indicated enhanced Ca<sup>2+</sup>mediated cellular stress in treated cells. In vivo evaluation in a xenograft mouse model revealed tumor inhibition rates of 42%, 24%, 60%, 78%, and 92% for GFT, CS-pDA, CS-pDA@Ca<sup>2 +</sup>/GFT, CTX-CS-pDA@Ca<sup>2 +</sup>/GFT, and CTX-CS-pDA@Ca<sup>2 +</sup>/GFT + NIR, respectively. The NIR-activated CTX-CS-pDA@Ca<sup>2 +</sup>/GFT formulation achieved the most pronounced tumor regression with negligible impact on body weight, confirming its superior therapeutic efficacy and biosafety. Biochemical analyses of serum ALP, SGOT, urea, and creatinine levels confirmed the biocompatibility and safety of the fabricated hydrogel. Histopathological examination of excised tumor tissues supported the induction of apoptosis and tissue necrosis in treated groups. Furthermore, qRT-PCR and Western blot analyses demonstrated upregulation of Bax and cleaved caspase-3 and downregulation of Bcl-2 and EGFR/p-AKT signaling, supporting the dual mechanism of action. Besides, CTX-CS-pDA@Ca<sup>2 +</sup>/GFT + NIR significantly upregulated pro-inflammatory cytokines (IL-6, TNF-α, and IFN-γ), indicating potential immunomodulatory activity associated with cytokine expression changes driven by targeted delivery, Ca<sup>2 +</sup> -mediated stress, and NIR-triggered activation. Overall, this multifunctional hydrogel demonstrates strong potential as a localized and targeted therapeutic strategy for EGFR-overexpressing esophageal cancer through synergistic EGFR inhibition, Ca<sup>2 +</sup> -mediated cytotoxicity, and potential immunomodulatory effects.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13679030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书